Exploring Medicinal Plant Legacy for Drug Discovery in Post-genomic Era

被引:15
|
作者
Singh S. [1 ]
Singh D.B. [2 ]
Singh S. [1 ]
Shukla R. [3 ]
Ramteke P.W. [4 ]
Misra K. [5 ]
机构
[1] Department of Computational Biology and Bioinformatics, JSBB, SHIATS, Allahabad
[2] Department of Biotechnology, Institute of Biosciences and Biotechnology, Chhatrapati Shahu Ji Maharaj University, Kanpur
[3] Department of Biochemistry, North Eastern Hill University, Shillong, 793022, Meghalaya
[4] Department of Biological Sciences, SHIATS, Allahabad
[5] Indian Institute of Information Technology, Allahabad, Allahabad
关键词
Bioprospecting; Computational approaches; Genomic; Indian medicinal plants; Reverse pharmacology;
D O I
10.1007/s40011-018-1013-x
中图分类号
学科分类号
摘要
Plants are a valuable source of pharmacologically important compounds since these are traditionally important in medicinal systems. Medicinal plant-based ancient wisdom could serve as a powerful tool to facilitate focused research on natural compounds for the drug discovery process. Medicinal plants are more important sources for drug discovery, specifically lead molecules as these offer several advantages over the synthetic molecules. Since in post genomic era, molecular targets for most diseases are known, conventional bioscreening strategies for medicinal plants are not sufficient to fulfill the present demand. It makes the role of medicinal plants more significant than ever before. The rich heritage of Indian medicinal plants can be explored utilizing various computational approaches for bioprospecting in the post-genomic era. In this review, the authors explore how Indian medicinal plant legacy can be utilized in post-genomic era utilizing the computational, bioinformatics, chemo-informatics, genomics and systems biology approaches. This approach shall make possible the systematic analysis integrating traditional and modern data in order to validate medicinal plant based knowledge. © 2018, The National Academy of Sciences, India.
引用
收藏
页码:1141 / 1151
页数:10
相关论文
共 50 条
  • [1] Fulfilling the promise: drug discovery in the post-genomic era
    Chanda, SK
    Caldwell, JS
    DRUG DISCOVERY TODAY, 2003, 8 (04) : 168 - 174
  • [2] Metabolic modeling: a tool of drug discovery in the post-genomic era
    Voit, EO
    DRUG DISCOVERY TODAY, 2002, 7 (11) : 621 - 628
  • [3] Insecticide discovery in the "post-genomic" era
    Soderlund, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 592 - 592
  • [4] The Legacy of Renato Dulbecco in the Post-Genomic Era
    Abenavoli, Ludovico
    Boccuto, Luigi
    MEDICINA-LITHUANIA, 2022, 58 (08):
  • [5] Plant proteomics in the post-genomic era
    Guo, YM
    Shen, SH
    Jing, YX
    Kuang, TY
    ACTA BOTANICA SINICA, 2002, 44 (06): : 631 - 641
  • [6] Target Discovery and Validation in the Post-Genomic Era
    Steven P. Butcher
    Neurochemical Research, 2003, 28 : 367 - 371
  • [7] Target discovery and validation in the post-genomic era
    Butcher, SP
    NEUROCHEMICAL RESEARCH, 2003, 28 (02) : 367 - 371
  • [8] Exploring prostate cancer in the post-genomic era
    Chua, Chee Wai
    Julio, Marianna Kruithof-de
    CANCER LETTERS, 2023, 553
  • [9] Plant developmental biology in the post-genomic era
    Sinha, Neelima Roy
    FRONTIERS IN PLANT SCIENCE, 2011, 2
  • [10] Plant secondary metabolism in the post-genomic era
    Oksman-Caldentey, K. M.
    Häkkinen, S. T.
    Rischer, H.
    Ritala, A.
    Ma, R.
    Seppänen-Loakso, T.
    Goossens, A.
    Oresic, M.
    Inzé, D.
    PLANTA MEDICA, 2006, 72 (11) : 963 - 963